ID: MRFR/MED/1574-HCR | February 2021 | Region: Global | 85 pages
Market Synopsis of Global Sepsis Diagnostics Market
Sepsis is a type of life-threatening organ dysfunction arises when the body's response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds. It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis, which is one of the driving factor for sepsis diagnostics market.
The global market for sepsis diagnostics is expected to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.
Study Objectives of Global Sepsis Diagnostics Market
Global Sepsis Diagnostics Market, by Technology, 2015 (%):
Key Players for Global Sepsis Diagnostics Market:
Some of the key players in this market are: bioMérieux, Inc. (US), EKF Diagnostics (UK), Immunexpress (US), T2 Biosystems, Inc. (US), Becton, Dickinson and Company (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), Sandstone Diagnostics, Inc. (US) and others.
Global sepsis diagnostics market has been segmented on the basis of technology which comprises molecular diagnostics, biomarkers, immunoassays and others. On the basis of type of product product types; the market is segmented into kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.
Regional Analysis of Global Sepsis Diagnostics Market:
Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.
Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.
The report of global sepsis diagnostics market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and projected future market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. Along with all these detail information and strategies about top key players in the industry is also given. Further a broad study of different markets segments and regions is also provided.
Frequently Asked Questions (FAQ) :
Sepsis Diagnostics Market is projected grow at 8% CAGR during the assessment period (2016-2022).
The valuation of the global sepsis diagnostics market is estimated to increase to USD 710 MN by the end of 2022.
Growing investments from industry players and the enhanced collection of patient outcome information and incorporation into medical records are the major tailwinds pushing the growth of the global sepsis diagnostics market.
North America holds the largest share in the global sepsis diagnostics market, followed by Europe and the Asia Pacific, respectively.
T2 Biosystems, Inc. (US), EKF Diagnostics (UK), bioMérieux, Inc. (US), Sandstone Diagnostics, Inc. (US), Becton, Dickinson and Company (US), Immunexpress (US), Cube Dx GmbH (Austria), and Axis-Shield Diagnostics Ltd. (Scotland), are some of the major players operating in the sepsis diagnostics market.